MarketCap
Facebook
X
Telegram
Deciphera Pharmaceuticals EV | DCPH
EV Jährlich Deciphera Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.24 B | 1.29 B | 486 M | 2.4 B | 2.24 B | 747 M | 239 M | -51.4 M | 116 M | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.4 B | -51.4 M | 967 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
ANI Pharmaceuticals
ANIP
|
1.86 B | $ 71.09 | -0.22 % | $ 1.43 B |  USA |
 |
Actinium Pharmaceuticals
ATNM
|
26.8 M | $ 1.59 | 1.27 % | $ 49.6 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
629 M | $ 1.24 | -6.06 % | $ 330 M |  Britain |
 |
BridgeBio Pharma
BBIO
|
15.5 B | $ 79.53 | 1.09 % | $ 15.2 B | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
2.8 B | $ 7.66 | 1.73 % | $ 1.61 B | USA |
 |
Bicycle Therapeutics plc
BCYC
|
-169 M | $ 3.69 | -0.14 % | $ 256 M | Britain |
 |
Coherus BioSciences
CHRS
|
335 M | $ 0.58 | -8.97 % | $ 67.9 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
3.64 B | $ 28.37 | 3.6 % | $ 3.61 B | USA |
 |
Cellectis S.A.
CLLS
|
522 M | $ 1.35 | 21.62 % | $ 135 M |  France |
 |
BeyondSpring
BYSI
|
111 M | $ 0.64 | 10.75 % | $ 26.3 M | USA |
 |
Alkermes plc
ALKS
|
5.41 B | $ 47.94 | 3.16 % | $ 7.9 B |  Irlanda |
 |
Altimmune
ALT
|
329 M | $ 1.94 | -0.21 % | $ 171 M | USA |
 |
Cardiff Oncology
CRDF
|
115 M | $ 0.76 | -4.57 % | $ 50.8 M | USA |
 |
Novartis AG
NVS
|
369 B | $ 160.35 | -1.79 % | $ 311 B |  Schweiz |
 |
Citius Pharmaceuticals
CTXR
|
57.7 M | $ 0.49 | -1.36 % | $ 5.42 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
43.4 M | $ 9.32 | -0.75 % | $ 255 M |  Israel |
 |
Arrowhead Pharmaceuticals
ARWR
|
6.02 B | $ 49.35 | 0.71 % | $ 6.6 B | USA |
 |
Atara Biotherapeutics
ATRA
|
124 M | $ 8.27 | 2.1 % | $ 104 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
1.95 B | $ 16.22 | -0.49 % | $ 2.18 B |  Canada |
 |
Cullinan Management
CGEM
|
850 M | $ 11.33 | 0.89 % | $ 683 M | USA |
 |
BioNTech SE
BNTX
|
17.1 B | $ 87.68 | 0.54 % | $ 21.2 B |  Germany |
 |
Collegium Pharmaceutical
COLL
|
2.52 B | $ 24.8 | 1.35 % | $ 785 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
119 M | $ 3.99 | 1.53 % | $ 53.1 M | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
434 M | $ 1.24 | 3.33 % | $ 56.7 M | Israel |
 |
AnaptysBio
ANAB
|
1.46 B | $ 48.73 | 0.72 % | $ 1.41 B | USA |
 |
Assembly Biosciences
ASMB
|
301 M | $ 22.36 | 4.73 % | $ 251 M | USA |
 |
Adagene
ADAG
|
176 M | $ 2.14 | 4.39 % | $ 126 M |  China |
 |
Benitec Biopharma
BNTC
|
388 M | $ 9.47 | 2.05 % | $ 441 M | USA |
 |
Denali Therapeutics
DNLI
|
2.34 B | $ 19.74 | -0.55 % | $ 3.41 B | USA |
 |
Amarin Corporation plc
AMRN
|
5.88 B | $ 11.68 | -0.64 % | $ 4.85 B | Irlanda |
 |
ImmuCell Corporation
ICCC
|
69.7 M | $ 10.19 | -0.7 % | $ 92 M | USA |
 |
Editas Medicine
EDIT
|
218 M | $ 2.38 | -4.99 % | $ 211 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
1.65 B | $ 32.84 | 3.38 % | $ 1.9 B | USA |
 |
Cue Biopharma
CUE
|
18 M | $ 19.08 | 1.71 % | $ 1.81 B | USA |
 |
Equillium
EQ
|
91.1 M | $ 1.41 | -3.09 % | $ 80.8 M | USA |
 |
Black Diamond Therapeutics
BDTX
|
134 M | $ 1.61 | 0.63 % | $ 91.6 M | USA |
 |
Abeona Therapeutics
ABEO
|
234 M | $ 2.35 | -4.28 % | $ 124 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
3.81 B | $ 18.38 | 0.55 % | $ 3.09 B | USA |
 |
PainReform Ltd.
PRFX
|
1.3 M | $ 0.74 | -6.69 % | $ 480 K | Israel |
 |
Atossa Therapeutics
ATOS
|
13.6 M | $ 2.04 | -4.67 % | $ 17.6 M | USA |
 |
Cleveland BioLabs, Inc.
CBLI
|
-29.8 M | - | -7.31 % | $ 49 M | USA |
 |
PDS Biotechnology Corporation
PDSB
|
19.6 M | $ 1.01 | -1.46 % | $ 46.8 M | USA |
 |
Five Prime Therapeutics, Inc.
FPRX
|
880 M | - | - | $ 1.77 B | USA |
 |
ADC Therapeutics SA
ADCT
|
386 M | $ 1.6 | 5.3 % | $ 203 M | Schweiz |
 |
Harmony Biosciences Holdings
HRMY
|
1.26 B | $ 34.22 | 2.0 % | $ 1.97 B | USA |
 |
Ardelyx
ARDX
|
1.89 B | $ 3.14 | 4.15 % | $ 757 M | USA |
 |
Akebia Therapeutics
AKBA
|
493 M | $ 0.57 | 5.2 % | $ 147 M | USA |
 |
Alector
ALEC
|
444 M | $ 2.62 | 3.56 % | $ 270 M | USA |
 |
ALX Oncology Holdings
ALXO
|
131 M | $ 1.12 | 0.9 % | $ 60.1 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
4.03 B | $ 21.71 | 1.52 % | $ 6.8 B | USA |